HighVista Strategies’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.8M Sell
56,602
-16,685
-23% -$1.7M 1.6% 10
2025
Q4
$7.37M Sell
73,287
-20,007
-21% -$1.97M 1.9% 8
2025
Q3
$8.07M Buy
93,294
+42,834
+85% +$3.39M 1.98% 7
2025
Q2
$3.85M Buy
50,460
+10,584
+27% +$774K 1.41% 10
2025
Q1
$2.83M Hold
39,876
1.09% 16
2024
Q4
$3.12M Buy
39,876
+10,858
+37% +$1.01M 1.16% 19
2024
Q3
$2.97M Buy
29,018
+320
+1% +$26.5K 1.02% 30
2024
Q2
$2.18M Sell
28,698
-31,313
-52% -$2.23M 0.8% 38
2024
Q1
$4.51M Buy
60,011
+5,928
+11% +$472K 1.61% 8
2023
Q4
$3.98M Hold
54,083
1.44% 16
2023
Q3
$2.49M Sell
54,083
-18,215
-25% -$808K 1.15% 23
2023
Q2
$3.05M Buy
72,298
+59,093
+448% +$2.23M 1.39% 18
2023
Q1
$345K Buy
+13,205
New +$391K 0.28% 82

Other funds holding NUVL

HighVista Strategies's NUVL Position: Q1 2026 in Review

HighVista Strategies reduced its Nuvalent (NUVL) stake by 23% in Q1 2026, selling an estimated $1.7M and leaving 56,602 shares worth $5.8M. The position accounts for 1.6% of the portfolio, ranked #10.

HighVista Strategies first reported a position in NUVL in Q1 2023 and has held it in 13 quarters since. The position peaked at $8.07M in Q3 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • HighVista Strategies held 56,602 shares of Nuvalent worth $5.8M as of Q1 2026.
  • HighVista Strategies sold 16,685 Nuvalent shares in Q1 2026, an estimated $1.7M.
  • Nuvalent made up 1.6% of HighVista Strategies's portfolio in Q1 2026, its #10 holding.
  • HighVista Strategies first reported a position in Nuvalent in Q1 2023 and has held it in 13 quarters since.
  • HighVista Strategies's Nuvalent position peaked at $8.07M in Q3 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.